Mutagenicity of Cancer Chemotherapeutic Agents in the Salmonella/Microsome Test

Cancer Research

Volumn 37, Issue , 1977, Pages 2209-2213

  Benedicl, William F ^b   Baker, Mary S ^b   Ames, Bruce N ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84965818560     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Abell. C. W., Falk. H. L., Shimkin. M. B., Weisburger. E. K., Weisburger, J. H., and Gubareff. N. Uracil Mustard: A Potent Inducer of Lung Tumors in Mice. Science, 147: 1443-1445.1965.
2. Ames. B. N. The Detection of Chemical Mutagens with Enteric Bacteria. In: A. Hollaender (ed.). Chemical Mutagens: Principles and Methods for Their Detection. Vol. 1. pp. 267–282. New York: Plenum Press. 1971.
3. Ames. B. N., Durston. W. E., Yamasaki. E., and Lee. F. D. Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection. Proc. Natl. Acad. Sci. U. S., 70: 2281-2285, 1973.
4. Ames. B. N., Lee. F. D., and Durston. W. E. An Improved Bacterial Test System for the Detection and Classification of Mutagens and Carcinogens. Proc. Natl. Acad. Sci. U. S., 70: 782–786. 1973.
5. Ames. B. N., McCann. J., and Yamasaki, E. Methods for Detecting Carcinogens and Mutagens with the Salmonella/Mammalian Microsome Mutagenicity Test. Mutation Res., 31: 347–364, 1975.
6. Benedict, W. F., Banerjee, A., Gardner, A., and Jones, P. A. Induction of Morphological Transformation in Mouse C3H/10½ Clone 8 Cells and Chromosomal Damage in Hamster A(T 1)C1-3 Cells by Cancer Chemotherapeutic Agents. Cancer Res., 37: 2203–2209, 1977.
7. Bertazzoli, C., Chieli. T., and Solcia, E. Different Incidence of Breast Carcinomas or Fibroadenomas in Daunomycin or Adriamycin Treated Rats. Experientia, 27: 1209–1210, 1971.
8. Clark. J. M. The Mutagenicity of Azathioprine in Mice, Drosophila Mela nogaster and Neurospora Crassa. Mutation Res., 28: 87-99,1975.
9. Colvin, M., Brundrett, R. B., Kan, M. N., Jardine. I., and Fenselau, C. Alkylating Properties of Phosphoramide Mustard. Cancer Res., 36:1121-1126, 1976.
10. DiPaolo, J. A. Experimental Evaluation of Actinomycin D. Ann. N. Y. Acad. Sci., 89: 408–420. 1960.
11. Doell, R. G., Cyr, C. deV., and Graber, P. Immune Reactivity Prior to Development of Thymic Lymphoma in C57BL Mice. Intern. J. Cancer, 2: 103–108, 1967.
12. Ellenberger, J., and Mohn, G. R. Comparative Mutagenicity Testing of Cyclophosphamide and Some of Its Metabolites (Abstract). Mutation Res., 38: 120–121, 1976.
13. Generoso, W. M., Preston, R. J., and Brewen, J. G. 6-Mercaptopurine, an Inducer of Cytogenetic and Dominant-Lethal Effects in Premeiotic and Early Meiotic Germ Cells of Male Mice. Mutation Res., 28: 437–447, 1975.
14. Haese, W. H., and Bueding, E. Long-Term Hepatocellular Effects of Hycanthone and of Two Other Antischistosomal Drugs in Mice Infected with Schistosoma mansoni. J. Pharmacol. Exptl. Therap., 197: 703–713, 1976.
15. Hartman, P. E., Levine. K., Hartman, Z., and Berger, H. Hycanthone: A Frameshift Mutagen. Science. 172: 1058–1060, 1971.
16. Herbold, B., and Buselmaier, W. Induction of Point Mutations by Different Chemical Mechanisms in the Liver Microsomal Assay. Mutation Res., 40: 73–84, 1976.
17. Holden, H. E., Ray, V. E., Wahrenburg, M. G., and Zelenski, J. D. Mutagenicity Studies with 6-Mercaptopurine: I. Cytogenetic Activity in Vivo. Mutation Res., 20: 257–263, 1973.
18. Kawamata. J., Nakabayashi, N., Kawai, A., and Ushida, T. Experimental Production of Sarcoma in Mice with Actinomycin. Med. J. Osaka Univ., 8: 753–762, 1958.
19. Koller, P. C. Dicentric Chromosomes in a Rat Tumor Induced by an Aromatic Nitrogen Mustard. Heredity, 6: 181–196, 1953.
20. Kross, L. G., and Lavin, P. Effects of a Single Dose of Cyclophosphamide on Various Organs of the Rat. II. Response of Urinary Bladder Epithelium According to Strain and Sex. J. Natl. Cancer Inst., 44: 1195-1200,1970.
21. Llombart, A. Tumoral Drugs as Possible Blastogenic Agents. Austrian J. Oncol., 3: 72–77, 1976.
22. Marquardt, H., Philips, F. S., and Sternberg, S. S. Tumorigenicity in Vivo and Induction of Malignant Transformation and Mutagenesis in Cell Cultures by Adriamycin and Daunomycin. Cancer Res., 36: 2065–2069, 1976.
23. McCann, J., and Ames, B. N. Detection of Carcinogens as Mutagens in the Salmonella/Microsome Test: Assay of 300 Chemicals: Discussion. Proc. Natl. Acad. Sci. U. S., 73: 950–954, 1976.
24. McCann, J., and Ames, B. N. The Salmonella/Microsome Mutagenicity Test: Predictive Value for Animal Carcinogenicity. In: J. D. Watson, H. Hiatt, and J. A. Winsten (eds.), Origins of Human Cancer. Cold Spring Harbor, N. Y.: Cold Spring Harbor Laboratory, pp. 553-561,1977.
25. McCann, J., Choi, E., Yamasaki, E., and Ames, B. N. Detection of Carcinogens as Mutagens in the Salmonella/Microsome Test: Assay of 300 Chemicals. Proc. Natl. Acad. Sci. U. S., 72: 5135–5139, 1975.
26. McCann, J., Simmon, V., Streitwieser, D., and Ames, B. N. Mutagenicity of Chloroacetaldehyde, a Possible Metabolic Product of 1,2-Dichloroe-thane (Ethylene Dichloride), Chloroethanol (Ethylene Chlorohydrin), Vinyl Chloride, and Cyclophosphamide. Proc. Natl. Acad. Sci. U. S., 72: 3190–3193, 1975.
27. McCann, J., Spingarn, N. E., Kobori, J., and Ames. B. N. Detection of Carcinogens as Mutagens: Bacterial Tester Strains with R Factor Plas-mids. Proc. Natl. Acad. Sci. U. S., 72: 979–983. 1975.
28. Minnich, V., Smith, M. E., Thompson, D., and Kornfeld. S. Detection of Mutagenic Activity in Human Urine Using Mutant Strains of Salmonella typhimurium. Cancer, 38: 1253–1258, 1976.
29. Monti-Bragadin, C., Tamaro, M., and Banfi, E. Mutagenic Activity of Platinum and Ruthenium Complexes. Chem.-Biol. Interactions, 11: 469–472, 1975.
30. Philips, F. S., Gilladoga, A., Marquardt, H., Sternberg, S. S., and Vidal, P. M. Some Observations on the Toxicity of Adriamycin. Cancer Chemotherapy Rept., 6 (Part 3): 177-181,1975.
31. Prejean, J. D., Griswold, D. P., Casey, A. E., Peckham, J. C., Weisburger, J. H., Weisburger, E. K., and Wood, H. B., Jr. Carcinogenicity Studies of Clinically Used Anticancer Agents (Abstract). Proc. Am. Assoc. Cancer Res., 13: 112, 1972.
32. Purchase, I. F. H., Longstaff, E., Ashby, J., Styles, J. A., Anderson, D., Lefevre, P. A., and Westwood, F. R. Evaluation of Six Short Term Tests for Detecting Organic Chemical Carcinogens and Recommendations for Their Use. Nature, 264: 624–627, 1976.
33. Ray, V., Ellis. J. H., Jr., and Holden, H. E. Point Mutation Assays Using Bacterial Indicators (Abstract). Mutation Res., 31: 310, 1975.
34. Rustia, M., and Shubik, P. Life-Span Carcinogenicity Tests with 4-Amino-N 10-methylpteroylglutamic Acid (Methotrexate) in Swiss Mice and Syrian Golden Hamsters. Toxicol. Appl. Pharmacol., 26: 329–338, 1973.
35. Schmähl, V. D. Experimental Investigations with Anti-Cancer Drugs for Carcinogenicity with Special Reference to Immune-depression. Recent Results Cancer Res., 52: 18–28, 1975.
36. Shimkin, M. B., Weisburger, J. H., Weisburger, E. K., Gubareff, N., and Suntzeff, V. Bioassay of 29 Alkylating Chemicals by Pulmonary-Tumor Response in Strain A Mice. J. Natl. Cancer Inst., 36: 915–935, 1966.
37. Sieber, S. M. Cancer Chemotherapeutic Agents and Carcinogenesis. Cancer Chemotherapy Rept. 59; 915-918,1975.
38. Sieber, S. M., and Adamson, R. H. The Clastogenic, Mutagenic, Teratogenic and Carcinogenic Effects of Various Antineoplastic Agents. In: Pharmacological Basis of Cancer Chemotherapy, M. D. Anderson Hospital and Tumor Institute at Houston, pp. 401–468. Baltimore: The Williams & Wilkins Co., 1975.
39. Sieber, S. M., and Adamson, R. H. Toxicity of Antineoplastic Agents in Man: Chromosomal Aberrations. Antifertility Effects, Congenital Malformations, and Carcinogenic Potential. Advan. Cancer Res., 22: 57–155, 1975.
40. Speck, W. T., and Rosenkranz, H. S. Mutagenicity of Azathioprine. Cancer Res., 36: 108–109, 1976.
41. Sternberg, S. S., Philips, F. S., and Cronin, A. P. Renal Tumors and Other Lesions in Rats following a Single Intravenous Injection of Daunomycin. Cancer Res., 32: 1029-1036,1972.
42. Stoner, G. D., Shimkin, M. B., Kniazeff, A. J., Weisburger, J. H., Weisburger, E. K., and Gori, G. B. Test for Carcinogenicity of Food Additives and Chemotherapeutic Agents by Pulmonary Tumor Response in Strain A Mice. Cancer Res., 33: 3069–3085. 1973.
43. Sugimura, T., Sato, S., Nagao, M., Yahagi, T., Matsushima, T., Seino, Y., Takeuchi, M., and Kawachi, T. Overlapping of Carcinogens and Mutagens. In: P. N. Magee et al. (eds.), Fundamentals in Cancer Prevention, pp. 191–215. Baltimore: University Park Press, 1976.
44. Svoboda, D., Reddy, J., and Harris, C. Invasive Tumors Induced in Rats with Actinomycin D. Cancer Res., 30: 2271–2279, 1970.
45. Thielde, T., and Christensen, B. C. Bladder Tumors Induced by Chlorna-phazine. Acta Med. Scand., 185: 133-137,1969.
46. Wall, R., and Clausen, K. Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide. N. Engl. J. Med., 293: 271–273, 1975.
47. Weisburger, J. H., Griswold, D. P., Jr., Prejean, J. D., Casey, A. E., Wood, H. B., Jr., and Weisburger, E. K. The Carcinogenic Properties of Some of the Principal Drugs Used in Clinical Cancer Chemotherapy. Recent Results Cancer Res., 52: 1–17, 1975.
48. Zimmer, D. M. Mutagenic Activity of Antitumor Drugs (Abstract). Proc. Am. Assoc. Cancer Res., 17: 96,1976.